IVD Test Procedure Volumes, 7th Edition (2025-2030)
Description
The global in vitro diagnostics (IVD) market continues to expand in 2025, driven by powerful innovations in next-generation sequencing (NGS), microfluidics, and precision medicine that are transforming diagnostics into a more personalized, patient-centric field. IVD Test Procedure Volumes, 7th Edition (2025-2030) provides a comprehensive, data-driven analysis of global test volume trends, serving as a critical companion to Kalorama Information’s flagship publication, The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 18th Edition (2025–2030).
Quantifying the Global Testing Landscape
This report delivers an in-depth examination of IVD procedures across major testing categories—including molecular diagnostics, clinical chemistry, immunoassays, hematology, coagulation, microbiology, blood banking, and histology/cytology. It quantifies the number of tests performed, the average cost per procedure, and regional variations across key markets worldwide. With forecasts extending through 2030, the study offers essential insight into test utilization trends, cost dynamics, and evolving regional testing patterns that are shaping the global diagnostics landscape.
Technological Advancements Reshaping Diagnostics
As the IVD industry evolves beyond pandemic-driven demand, new paradigms in self-testing, home-based diagnostics, and point-of-care (POC) solutions are accelerating accessibility and reshaping healthcare delivery. Meanwhile, growth in molecular and cancer diagnostics underscores the sector’s pivot toward early detection and non-invasive monitoring through liquid biopsy and genomic testing. These advancements align with the global push toward precision medicine—but also introduce new challenges related to cost, regulation, and equitable access.
Navigating Economic and Regulatory Pressures
This report contextualizes these market drivers within a rapidly changing regulatory and economic environment. With rising scrutiny under the EU’s IVDR and FDA’s evolving frameworks, manufacturers must navigate complex approval pathways while addressing payer pressures that impact reimbursement and adoption. The balance between technological advancement, affordability, and scalability will define the next stage of IVD growth.
Methodology and Strategic Value
Drawing on Kalorama’s proprietary methodologies, this study presents accurate, transparent, and actionable estimates of IVD procedure volumes and revenues—empowering executives, strategists, and investors to benchmark performance, identify growth opportunities, and align product portfolios with emerging diagnostic trends.
An Essential Resource for IVD Decision-Makers
For organizations seeking to understand where the IVD market is headed—and how procedural demand will drive innovation, investment, and access over the next five years—IVD Test Procedure Volumes, 7th Edition (2025-2030) is an indispensable resource for strategic decision-making.
Please Note: Single user allows for up to 3 users for this report.
Quantifying the Global Testing Landscape
This report delivers an in-depth examination of IVD procedures across major testing categories—including molecular diagnostics, clinical chemistry, immunoassays, hematology, coagulation, microbiology, blood banking, and histology/cytology. It quantifies the number of tests performed, the average cost per procedure, and regional variations across key markets worldwide. With forecasts extending through 2030, the study offers essential insight into test utilization trends, cost dynamics, and evolving regional testing patterns that are shaping the global diagnostics landscape.
Technological Advancements Reshaping Diagnostics
As the IVD industry evolves beyond pandemic-driven demand, new paradigms in self-testing, home-based diagnostics, and point-of-care (POC) solutions are accelerating accessibility and reshaping healthcare delivery. Meanwhile, growth in molecular and cancer diagnostics underscores the sector’s pivot toward early detection and non-invasive monitoring through liquid biopsy and genomic testing. These advancements align with the global push toward precision medicine—but also introduce new challenges related to cost, regulation, and equitable access.
Navigating Economic and Regulatory Pressures
This report contextualizes these market drivers within a rapidly changing regulatory and economic environment. With rising scrutiny under the EU’s IVDR and FDA’s evolving frameworks, manufacturers must navigate complex approval pathways while addressing payer pressures that impact reimbursement and adoption. The balance between technological advancement, affordability, and scalability will define the next stage of IVD growth.
Methodology and Strategic Value
Drawing on Kalorama’s proprietary methodologies, this study presents accurate, transparent, and actionable estimates of IVD procedure volumes and revenues—empowering executives, strategists, and investors to benchmark performance, identify growth opportunities, and align product portfolios with emerging diagnostic trends.
An Essential Resource for IVD Decision-Makers
For organizations seeking to understand where the IVD market is headed—and how procedural demand will drive innovation, investment, and access over the next five years—IVD Test Procedure Volumes, 7th Edition (2025-2030) is an indispensable resource for strategic decision-making.
Please Note: Single user allows for up to 3 users for this report.
Table of Contents
275 Pages
- IVD Procedure Volume Estimate and Forecast
- Scope & Methodology
- About Kalorama Information
- Scope
- Overview
- Industry Trends
- Demographic Trends
- WHO Essential IVD List
- Increase in Chronic Diseases
- Personalized Medicine
- High-Consequence Disease Threats
- Emerging and Emerged Markets
- IVD Testing Trends
- Segment Growth Projections
- Segment Product Sales
- General
- North America
- Mexico, Central, &South America
- Western Europe
- Eastern Europe
- Asia/Pacific
- Middle East
- Africa
- Scope
- Introduction
- Global POC Procedure Volume by Test Type
- POC Self Tests
- POC Self-Testing Product Sales
- Pricing Trends
- POC Professional Testing
- POC IVD Product Sales
- Pricing Trends
- Scope
- Introduction
- Types of Tests
- Global Sales of Clinical Chemistry Products
- Pricing Trends
- Scope
- Introduction
- Labeling Techniques
- Testing Procedures & Product Sales
- Instruments
- Pricing Trends
- Scope
- Introduction
- Types of Tests
- Global Sales of Molecular IVD Products
- Pricing Trends
- Scope
- Introduction
- Types of Tests
- Global Sales of Hematology Products
- Pricing Trends
- Scope
- Introduction
- Types of Tests
- Global Sales of Coagulation Products
- Pricing Trends
- Scope
- Introduction
- Types of Tests
- Global Sales of Conventional IVD Microbiology Products
- Pricing Trends
- Scope
- Introduction
- Types of Tests
- Blood Grouping/Typing Product Sales
- Pricing Trends
- Scope
- Introduction
- Types of Tests
- Histology/Cytology IVD Product Sales
- Pricing Trends
- Scope
- Introduction
- Abbott Diagnostics
- Agilent Technologies
- Becton, Dickinson and Company (BD)
- bioMérieux Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Dexcom
- Diasorin
- Exact Sciences
- Hologic, Inc.
- Illumina
- Mindray - Shenzhen Mindray Bio-medical Electronics Co., Ltd.
- Natera
- QuidelOrtho Corporation
- Revvity
- Roche Diagnostics
- Siemens Healthineers (Siemens)
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Werfen
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
